NA
CRL icon

NewEdge Advisors’s Charles River Laboratories CRL Stock Holding History

NewEdge Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$961K Buy
4,236
+1,041
+33% +$185K ﹤0.01% 1693
2026
Q1 		$551K Buy
3,195
+2,933
+1,119% +$544K ﹤0.01% 1907
2025
Q4 		$52.3K Hold
262
– – ﹤0.01% 2946
2025
Q3 		$41K Sell
262
-180
-41% -$28.6K ﹤0.01% 2887
2025
Q2 		$67.1K Buy
442
+4
+0.9% +$533 ﹤0.01% 2574
2025
Q1 		$65.9K Sell
438
-86
-16% -$14.4K ﹤0.01% 2449
2024
Q4 		$96.7K Sell
524
-122
-19% -$23.5K ﹤0.01% 2290
2024
Q3 		$127K Sell
646
-1,668
-72% -$347K ﹤0.01% 2122
2024
Q2 		$478K Sell
2,314
-1,025
-31% -$232K ﹤0.01% 1447
2024
Q1 		$905K Buy
3,339
+812
+32% +$194K 0.01% 1047
2023
Q4 		$553K Buy
2,527
+469
+23% +$92.2K 0.01% 1229
2023
Q3 		$403K Buy
2,058
+206
+11% +$42.3K ﹤0.01% 1281
2023
Q2 		$389K Buy
1,852
+92
+5% +$18.3K ﹤0.01% 1317
2023
Q1 		$355K Buy
1,760
+474
+37% +$107K ﹤0.01% 1293
2022
Q4 		$263K Buy
+1,286
New +$281K 0.01% 1069
2022
Q1 		– Sell
-2,670
Closed -$1.01M – 1244
2021
Q4 		$1.01M Sell
2,670
-1,634
-38% -$635K 0.02% 729
2021
Q3 		$1.78M Buy
4,304
+786
+22% +$326K 0.04% 345
2021
Q2 		$1.3M Buy
+3,518
New +$1.17M 0.03% 413
2017
Q3 		– Sell
-22
Closed -$2.18K – 507
2017
Q2 		$2.18K Buy
+22
New +$2.02K ﹤0.01% 1292

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

NewEdge Advisors's CRL Position: Q2 2026 in Review

NewEdge Advisors increased its Charles River Laboratories (CRL) stake by 33% in Q2 2026, buying an estimated $185K and bringing the position to 4,236 shares worth $961K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

NewEdge Advisors first reported a position in CRL in Q2 2017 and has held it in 19 quarters since. The position peaked at $1.78M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • NewEdge Advisors held 4,236 shares of Charles River Laboratories worth $961K as of Q2 2026.
  • NewEdge Advisors bought 1,041 Charles River Laboratories shares in Q2 2026, an estimated $185K.
  • Charles River Laboratories made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1693 holding.
  • NewEdge Advisors first reported a position in Charles River Laboratories in Q2 2017 and has held it in 19 quarters since.
  • NewEdge Advisors's Charles River Laboratories position peaked at $1.78M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.